When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Dexcom - Wikipedia

   en.wikipedia.org/wiki/Dexcom

   Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. [3] [4] In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours ...

3. Continuous glucose monitor - Wikipedia

   en.wikipedia.org/wiki/Continuous_glucose_monitor

   The "transmitter" receives data from the sensor every 5 minutes and forwards that data to a nearby device wirelessly. However unlike the Freestyle Libre, the implanted device is too small to have its own battery and memory, so that no glucose readings are generated during periods in which the transmitter is not being worn. [ 28 ]

4. Glucose meter - Wikipedia

   en.wikipedia.org/wiki/Glucose_meter

   The Dexcom System is another system, available in two different generations in the US, the G4 and the G5. (1Q 2016). It is a hypodermic probe with a small transmitter. The receiver is about the size of a cell phone and can operate up to twenty feet from the transmitter. The Dexcom G4 transmits via radio frequency and requires a dedicated ...

5. Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years

   www.aol.com/finance/got-2-000-2-top-134500278.html

   DexCom (NASDAQ: DXCM) is one of the global leaders in the continuous glucose monitoring device (CGM) industry, a segment of the diabetes care space. The company's CGMs have use cases for a broad ...

6. 1 Reason to Sell DexCom Stock, and 1 Reason to Buy - AOL

   www.aol.com/1-reason-sell-dexcom-stock-114500360...

   Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a ...

7. Is DexCom a Millionaire Maker? - AOL

   www.aol.com/dexcom-millionaire-maker-120700315.html

   Right now, DexCom's stock is valued at a price-to-earnings (P/E) multiple of 42. Assuming that valuation holds up over time, it'd have a market cap of roughly $469 billion in 2034, or 1,605% ...